Lheureux S, Braunstein M, Oza AM. Epithelial ovarian cancer: evolution of management in the era of precision medicine. CA Cancer J Clin. 2019;69(4):280–304.

Article  PubMed  Google Scholar 

Gaona-Luviano P, Medina-Gaona LA, Magaña-Pérez K. Epidemiology of ovarian cancer. Chin Clin Oncol. 2020;9(4):47.

Article  PubMed  Google Scholar 

Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowicz CD, Gaudet MM, Jemal A, Siegel RL. Ovarian cancer statistics, 2018. CA Cancer J Clin. 2018;68(4):284–96.

Article  PubMed  PubMed Central  Google Scholar 

Lheureux S, Gourley C, Vergote I, Oza AM. Epithelial ovarian cancer. Lancet. 2019;393(10177):1240–53.

Article  PubMed  Google Scholar 

Kim R. Effects of surgery and anesthetic choice on immunosuppression and cancer recurrence. J Translational Med. 2018;16(1):8.

Article  CAS  Google Scholar 

Chen Z, Zhang P, Xu Y, Yan J, Liu Z, Lau WB, Lau B, Li Y, Zhao X, Wei Y. Surgical stress and cancer progression: the twisted tango. Mol Cancer. 2019;18(1):1–11.

Article  PubMed  PubMed Central  Google Scholar 

Liu X, Wang Q. Application of anesthetics in Cancer patients: reviewing current existing Link with Tumor recurrence. Front Oncol. 2022;12:759057.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Xu YJ, Li SY, Cheng Q, Chen WK, Wang SL, Ren Y, Miao CH. Effects of anaesthesia on proliferation, invasion and apoptosis of LoVo colon cancer cells in vitro. Anaesthesia. 2016;71(2):147–54.

Article  PubMed  CAS  Google Scholar 

Soltanizadeh S, Degett TH, Gogenur I. Outcomes of cancer surgery after inhalational and intravenous anesthesia: a systematic review. J Clin Anesth. 2017;42:19–25.

Article  PubMed  Google Scholar 

Yap A, Lopez-Olivo MA, Dubowitz J, Hiller J, Riedel B. Global onco-anesthesia research collaboration G: anesthetic technique and cancer outcomes: a meta-analysis of total intravenous versus volatile anesthesia. Can J Anaesth. 2019;66(5):546–61.

Article  PubMed  Google Scholar 

Ramirez MF, Cata JP. Anesthesia techniques and long-term oncological outcomes. Front Oncol. 2021;11:788918.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chang CY, Wu MY, Chien YJ, Su IM, Wang SC, Kao MC. Anesthesia and long-term oncological outcomes: a systematic review and Meta-analysis. Anesth Analg. 2021;132(3):623–34.

Article  PubMed  Google Scholar 

Zhou X, Shao Y, Li S, Zhang S, Ding C, Zhuang L, Sun J. An intravenous anesthetic drug-propofol, influences the biological characteristics of malignant tumors and reshapes the tumor microenvironment: a narrative literature review. Front Pharmacol. 2022;13:1057571.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Xu Y, Pan S, Jiang W, Xue F, Zhu X. Effects of propofol on the development of cancer in humans. Cell Prolif. 2020;53(8):e12867.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Jiang S, Liu Y, Huang L, Zhang F, Kang R. Effects of propofol on cancer development and chemotherapy: potential mechanisms. Eur J Pharmacol. 2018;831:46–51.

Article  PubMed  CAS  Google Scholar 

Tseng W-C, Lee M-S, Lin Y-C, Lai H-C, Yu M-H, Wu K-L, Wu Z-F. Propofol-based total intravenous anesthesia is Associated with Better Survival than Desflurane Anesthesia in epithelial ovarian Cancer surgery: a retrospective cohort study. Front Pharmacol. 2021;12:685265.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zon A, Bednarek I. Cisplatin in ovarian cancer treatment-known limitations in therapy force new solutions. Int J Mol Sci. 2023;24(8):7585.

Basu A, Krishnamurthy S. Cellular responses to Cisplatin-induced DNA damage. J Nucleic Acids 2010, 2010:201367.

Dasari S, Tchounwou PB. Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol. 2014;740:364–78.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Guarneri V, Piacentini F, Barbieri E, Conte PF. Achievements and unmet needs in the management of advanced ovarian cancer. Gynecol Oncol. 2010;117(2):152–8.

Article  PubMed  CAS  Google Scholar 

Galluzzi L, Senovilla L, Vitale I, Michels J, Martins I, Kepp O, Castedo M, Kroemer G. Molecular mechanisms of cisplatin resistance. Oncogene. 2012;31(15):1869–83.

Article  PubMed  CAS  Google Scholar 

Lawrie TA, Bryant A, Cameron A, Gray E, Morrison J. Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer. Cochrane Database Syst Rev. 2013;2013(7):CD006910.

PubMed  PubMed Central  Google Scholar 

Nitiss JL. Targeting DNA topoisomerase II in cancer chemotherapy. Nat Rev Cancer. 2009;9(5):338–50.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bayat Mokhtari R, Homayouni TS, Baluch N, Morgatskaya E, Kumar S, Das B, Yeger H. Combination therapy in combating cancer. Oncotarget. 2017;8(23):38022–43.

Article  PubMed  Google Scholar 

Pritchard JR, Bruno PM, Gilbert LA, Capron KL, Lauffenburger DA, Hemann MT. Defining principles of combination drug mechanisms of action. Proc Natl Acad Sci U S A. 2013;110(2):E170–179.

Article  PubMed  CAS  Google Scholar 

Mammoto T, Mukai M, Mammoto A, Yamanaka Y, Hayashi Y, Mashimo T, Kishi Y, Nakamura H. Intravenous anesthetic, propofol inhibits invasion of cancer cells. Cancer Lett. 2002;184(2):165–70.

Article  PubMed  CAS  Google Scholar 

Kushida A, Inada T, Shingu K. Enhancement of antitumor immunity after propofol treatment in mice. Immunopharmacol Immunotoxicol. 2007;29(3–4):477–86.

Article  PubMed  CAS  Google Scholar 

Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, Doig A, Guilliams T, Latimer J, McNamee C, et al. Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov. 2019;18(1):41–58.

Article  PubMed  CAS  Google Scholar 

El-Deiry WS. The role of p53 in chemosensitivity and radiosensitivity. Oncogene. 2003;22(47):7486–95.

Article  PubMed  CAS  Google Scholar 

Hientz K, Mohr A, Bhakta-Guha D, Efferth T. The role of p53 in cancer drug resistance and targeted chemotherapy. Oncotarget. 2017;8(5):8921–46.

Article  PubMed  Google Scholar 

Cocetta V, Ragazzi E, Montopoli M. Mitochondrial involvement in Cisplatin Resistance. Int J Mol Sci. 2019;20(14):3384.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zong WX, Rabinowitz JD, White E. Mitochondria and Cancer. Mol Cell. 2016;61(5):667–76.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Guerra F, Arbini AA, Moro L. Mitochondria and cancer chemoresistance. Biochim Biophys Acta Bioenerg. 2017;1858(8):686–99.

Article  PubMed